Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Alberto Papi; Bradley E. Chipps; Richard Beasley; Reynold A. Panettieri; Elliot Israel; Mark Cooper; Lynn Dunsire; Allison Jeynes-Ellis; Robert Rees; Frank C. Albers; Christy Cappelletti

doi:10.1177/17534666241232264

Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Alberto Papi
, Bradley E. Chipps
, Richard Beasley
, Reynold A. Panettieri
, Elliot Israel
, Mark Cooper
, Lynn Dunsire
, Allison Jeynes-Ellis
, Robert Rees
, Frank C. Albers
, Christy Cappelletti

Rutgers Institute for Translational Medicine and Science

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

Original language	English (US)
Journal	Therapeutic Advances in Respiratory Disease
Volume	18
DOIs	https://doi.org/10.1177/17534666241232264
State	Published - Jan 1 2024

All Science Journal Classification (ASJC) codes

Pulmonary and Respiratory Medicine
Pharmacology (medical)

Access to Document

10.1177/17534666241232264

Cite this

Papi, A., Chipps, B. E., Beasley, R., Panettieri, R. A., Israel, E., Cooper, M., Dunsire, L., Jeynes-Ellis, A., Rees, R., Albers, F. C., & Cappelletti, C. (2024). Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666241232264

@article{e9dfac64204e44d48257880c093be425,

title = "Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study",

abstract = "What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA{\texttrademark}). This summary describes the results for people aged 18 yearsand older who took part in the study.",

author = "Alberto Papi and Chipps, \{Bradley E.\} and Richard Beasley and Panettieri, \{Reynold A.\} and Elliot Israel and Mark Cooper and Lynn Dunsire and Allison Jeynes-Ellis and Robert Rees and Albers, \{Frank C.\} and Christy Cappelletti",

note = "Publisher Copyright: {\textcopyright} The Author(s), 2024.",

year = "2024",

month = jan,

day = "1",

doi = "10.1177/17534666241232264",

language = "English (US)",

volume = "18",

journal = "Therapeutic Advances in Respiratory Disease",

issn = "1753-4658",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Albuterol–budesonide fixed-dose combination rescue inhaler for asthma

T2 - a plain language summary of the MANDALA study

AU - Papi, Alberto

AU - Chipps, Bradley E.

AU - Beasley, Richard

AU - Panettieri, Reynold A.

AU - Israel, Elliot

AU - Cooper, Mark

AU - Dunsire, Lynn

AU - Jeynes-Ellis, Allison

AU - Rees, Robert

AU - Albers, Frank C.

AU - Cappelletti, Christy

PY - 2024/1/1

Y1 - 2024/1/1

N2 - What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

AB - What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

UR - https://www.scopus.com/pages/publications/85192039162

UR - https://www.scopus.com/pages/publications/85192039162#tab=citedBy

U2 - 10.1177/17534666241232264

DO - 10.1177/17534666241232264

M3 - Article

C2 - 38698565

AN - SCOPUS:85192039162

SN - 1753-4658

VL - 18

JO - Therapeutic Advances in Respiratory Disease

JF - Therapeutic Advances in Respiratory Disease

ER -

Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this